In this study, we found that PD-related peritoneal fibrosis was associated with increased expression of EP4 and that administration of an EP4 receptor antagonist (ONO-AE3-208) prevented progressive peritoneal fibrosis and functional injury of the peritoneal membrane. The gene discussed is PTGER4; the disease is Peritoneal Fibrosis.